The following are Licensing Opportunities in Animal Science:
Guelph researchers have developed a vaccine for C. difficile for use in humans and are interested in investigating its use in animals.
Researchers at the University of Guelph have developed a method to evaluate the innate immune capability of cattle by measuring the bactericidal performance of their macrophages in response to common bovine pathogens. This in vitro serum-free test (immunophenotyping) measures the ability of monocyte-derived macrophages to produce and express nitric oxide (oxidative burst) used by macrophages during non-adaptive inflammatory immune interactions with E coli and S. aureus.
Researchers at the University of Guelph have discovered several single nucleotide polymorphisms (SNPs) associated with inflammatory diseases such as mastitis and Johne’s disease of dairy cattle. These genetic markers related to polymorphisms in the IL-10 receptor alpha gene can be used in breeding programs to reduce the incidence or severity of mastitis or Johne’s disease more cost-effectively than vaccination, antibiotics, or herd management practices.
Guelph researchers have developed a novel mouse model, which offers a unique opportunity to study disease progression, and examine various therapies and nutraceuticals that are indicated for treating obesity, MetS, diabetes, and other related CV diseases.
Researchers at the University of Saskatchewan and the University of Guelph have developed the first live multi-strain fowl adenovirus vaccine to prevent Inclusion Body Hepatitis in broiler chickens.